BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

551 related articles for article (PubMed ID: 16925908)

  • 1. Timing of highly active antiretroviral therapy and chemotherapy for Kaposi's sarcoma in patients with HIV infection.
    Loke WC; Spittle MF; Mitchell S; Kulasegaram R
    Int J STD AIDS; 2006 Aug; 17(8):565-6. PubMed ID: 16925908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of HIV-1-associated Kaposi's sarcoma with pegylated liposomal doxorubicin and HAART simultaneously induces effective tumor remission and CD4+ T cell recovery.
    Lichterfeld M; Qurishi N; Hoffmann C; Hochdorfer B; Brockmeyer NH; Arasteh K; Mauss S; Rockstroh JK;
    Infection; 2005 Jun; 33(3):140-7. PubMed ID: 15940415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma.
    Bihl F; Mosam A; Henry LN; Chisholm JV; Dollard S; Gumbi P; Cassol E; Page T; Mueller N; Kiepiela P; Martin JN; Coovadia HM; Scadden DT; Brander C
    AIDS; 2007 Jun; 21(10):1245-52. PubMed ID: 17545700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regression of Kaposi's sarcoma lesions following highly active antiretroviral therapy in an HIV-infected patient.
    Kumarasamy N; Venkatesh KK; Devaleenol B; Poongulali S; Ahilasamy N
    Int J STD AIDS; 2008 Nov; 19(11):786-8. PubMed ID: 18931277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diagnosis and treatment of HIV-related Kaposi's sarcoma].
    Reyners AK; Sprenger HG; Suurmeijer AJ; van der Graaf WT
    Ned Tijdschr Geneeskd; 2006 Mar; 150(11):589-93. PubMed ID: 16610494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [HAART and changes of epidemiology, treatment and prognosis of HIV-positive patients with Kaposi's sarcoma and lymphoma].
    Gabarre J; Bossi P
    Bull Cancer; 2003 May; 90(5):419-25. PubMed ID: 12850765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of Kaposi's sarcoma in resource-limited settings in the era of HAART.
    Lynen L; Zolfo M; Huyst V; Louis F; Barnardt P; Van de Velde A; De Schacht C; Colebunders R
    AIDS Rev; 2005; 7(1):13-21. PubMed ID: 15875657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pegylated liposomal doxorubicin plus highly active antiretroviral therapy versus highly active antiretroviral therapy alone in HIV patients with Kaposi's sarcoma.
    Martin-Carbonero L; Barrios A; Saballs P; Sirera G; Santos J; Palacios R; Valencia ME; Alegre M; Podzamczer D; González-Lahoz J;
    AIDS; 2004 Aug; 18(12):1737-40. PubMed ID: 15280789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring of endogenous interferon-alpha and human herpesvirus 8 in HIV-infected patients with Kaposi's sarcoma.
    Plettenberg A; Albrecht D; Lorenzen T; Meyer T; Arndt R; Stoehr A
    Eur J Med Res; 2002 Jan; 7(1):19-24. PubMed ID: 11827836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resolution of severe Kaposi's sarcoma after initiation of antiretroviral triple therapy.
    Jung C; Bogner JR; Goebel F
    Eur J Med Res; 1998 Sep; 3(9):439-42. PubMed ID: 9737891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Kaposi sarcoma in HIV patients: Response to antiretroviral treatment and chemotherapy].
    Lasso M; Pérez J; Noriega L; Malebrán A; Espinoza S
    Rev Med Chil; 2003 May; 131(5):483-90. PubMed ID: 12879808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kaposi's sarcoma in patients with human immunodeficiency virus infection in Taiwan.
    Lin CY; Chen MY; Hsieh SM; Sheng WH; Sun HY; Lo YC; Hung CC; Chang SC
    J Microbiol Immunol Infect; 2009 Jun; 42(3):227-33. PubMed ID: 19812856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Kaposi's sarcoma].
    Imamura A
    Gan To Kagaku Ryoho; 2003 May; 30(5):634-9. PubMed ID: 12795094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Highly active antiretroviral therapy for the treatment of Kaposi's sarcoma associated with primary human immunodeficiency virus type-1 infection.
    Genka I; Yasuoka A; Saitoh K; Oka S
    Jpn J Infect Dis; 2000 Aug; 53(4):166-7. PubMed ID: 11056560
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of severe or progressive Kaposi's sarcoma in HIV-infected adults.
    Gbabe OF; Okwundu CI; Dedicoat M; Freeman EE
    Cochrane Database Syst Rev; 2014 Aug; 8(8):CD003256. PubMed ID: 25221796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Remission from Kaposi's sarcoma on HAART is associated with suppression of HIV replication and is independent of protease inhibitor therapy.
    Martinez V; Caumes E; Gambotti L; Ittah H; Morini JP; Deleuze J; Gorin I; Katlama C; Bricaire F; Dupin N
    Br J Cancer; 2006 Apr; 94(7):1000-6. PubMed ID: 16570046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of AIDS-related Kaposi's sarcoma: advances in target discovery and treatment.
    Dezube BJ
    Expert Rev Anticancer Ther; 2002 Apr; 2(2):193-200. PubMed ID: 12113241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in Kaposi's sarcoma survival disparities in the United States: 1980 through 2004.
    Datta GD; Kawachi I; Delpierre C; Lang T; Grosclaude P
    Cancer Epidemiol Biomarkers Prev; 2010 Nov; 19(11):2718-26. PubMed ID: 20861396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Kaposi's sarcoma].
    Boué F; Lebbé C
    Bull Cancer; 2003 May; 90(5):393-8. PubMed ID: 12850761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between oral Kaposi 's sarcoma and HAART: contribution of two case reports.
    Campo-Trapero J; Del Romero-Guerrero J; Cano-Sánchez J; Rodríguez-Martín C; Martínez-González JM; Bascones-Martínez A
    Med Oral Patol Oral Cir Bucal; 2008 Nov; 13(11):E709-13. PubMed ID: 18978711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.